Key Points- Eli Lilly said its next-generation obesity drug delivered strong weight loss and reduced knee arthritis pain in a late-stage study, clearing the first of several upcoming trials on the weekly injection. – The drugmaker is betting big on the treatment, retatrutide, as the next pillar of its obesity portfolio after its weight loss […]
